Mirum Pharmaceuticals Inc. has granted inducement awards to 37 new employees, including non-qualified stock options to purchase 163,040 shares at an exercise price of $100.91 per share, 219,090 restricted stock units (RSUs), and 48,880 performance stock units (PSUs) under its 2020 Inducement Plan. Stock options will vest over four years, with 25% vesting after one year and the remainder vesting monthly over the next 36 months. RSUs will vest over three years in equal annual installments. PSUs are tied to achieving specific net product sales levels for the years ending December 31, 2027, and 2028, with vesting scheduled for March 2028 and March 2029 based on performance metrics.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mirum Pharmaceuticals Inc. published the original content used to generate this news brief on February 10, 2026, and is solely responsible for the information contained therein.